These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 32034098)

  • 1. PD-1+ stemlike CD8 T cells are resident in lymphoid tissues during persistent LCMV infection.
    Im SJ; Konieczny BT; Hudson WH; Masopust D; Ahmed R
    Proc Natl Acad Sci U S A; 2020 Feb; 117(8):4292-4299. PubMed ID: 32034098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T Cell Receptor Diversity and Lineage Relationship between Virus-Specific CD8 T Cell Subsets during Chronic Lymphocytic Choriomeningitis Virus Infection.
    Chang YM; Wieland A; Li ZR; Im SJ; McGuire DJ; Kissick HT; Antia R; Ahmed R
    J Virol; 2020 Sep; 94(20):. PubMed ID: 32759317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic signature of PD-1+ TCF1+ CD8 T cells that act as resource cells during chronic viral infection and respond to PD-1 blockade.
    Jadhav RR; Im SJ; Hu B; Hashimoto M; Li P; Lin JX; Leonard WJ; Greenleaf WJ; Ahmed R; Goronzy JJ
    Proc Natl Acad Sci U S A; 2019 Jul; 116(28):14113-14118. PubMed ID: 31227606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Lymphocytic Choriomeningitis Virus Strain Sustains Abundant Exhausted Progenitor CD8 T Cells without Systemic Viremia.
    Beura LK; Scott MC; Pierson MJ; Joag V; Wijeyesinghe S; Semler MR; Quarnstrom CF; Busman-Sahay K; Estes JD; Hamilton SE; Vezys V; O'Connor DH; Masopust D
    J Immunol; 2022 Nov; 209(9):1691-1702. PubMed ID: 36122933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection.
    Jin HT; Anderson AC; Tan WG; West EE; Ha SJ; Araki K; Freeman GJ; Kuchroo VK; Ahmed R
    Proc Natl Acad Sci U S A; 2010 Aug; 107(33):14733-8. PubMed ID: 20679213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PD-L1 Checkpoint Inhibition Narrows the Antigen-Specific T Cell Receptor Repertoire in Chronic Lymphocytic Choriomeningitis Virus Infection.
    Klein S; Ghersi D; Manns MP; Prinz I; Cornberg M; Kraft ARM
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32641478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of PD-1 during effector CD8 T cell differentiation.
    Ahn E; Araki K; Hashimoto M; Li W; Riley JL; Cheung J; Sharpe AH; Freeman GJ; Irving BA; Ahmed R
    Proc Natl Acad Sci U S A; 2018 May; 115(18):4749-4754. PubMed ID: 29654146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the role of the inhibitory receptor LAG-3 in acute and chronic LCMV infection.
    Richter K; Agnellini P; Oxenius A
    Int Immunol; 2010 Jan; 22(1):13-23. PubMed ID: 19880580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection.
    Matloubian M; Concepcion RJ; Ahmed R
    J Virol; 1994 Dec; 68(12):8056-63. PubMed ID: 7966595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-GITR agonist therapy intrinsically enhances CD8 T cell responses to chronic lymphocytic choriomeningitis virus (LCMV), thereby circumventing LCMV-induced downregulation of costimulatory GITR ligand on APC.
    Clouthier DL; Zhou AC; Watts TH
    J Immunol; 2014 Nov; 193(10):5033-43. PubMed ID: 25281716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interplay between regulatory T cells and PD-1 in modulating T cell exhaustion and viral control during chronic LCMV infection.
    Penaloza-MacMaster P; Kamphorst AO; Wieland A; Araki K; Iyer SS; West EE; O'Mara L; Yang S; Konieczny BT; Sharpe AH; Freeman GJ; Rudensky AY; Ahmed R
    J Exp Med; 2014 Aug; 211(9):1905-18. PubMed ID: 25113973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follicular CXCR5- expressing CD8(+) T cells curtail chronic viral infection.
    He R; Hou S; Liu C; Zhang A; Bai Q; Han M; Yang Y; Wei G; Shen T; Yang X; Xu L; Chen X; Hao Y; Wang P; Zhu C; Ou J; Liang H; Ni T; Zhang X; Zhou X; Deng K; Chen Y; Luo Y; Xu J; Qi H; Wu Y; Ye L
    Nature; 2016 Aug; 537(7620):412-428. PubMed ID: 27501245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of lymphotoxin alpha in T-cell responses during an acute viral infection.
    Suresh M; Lanier G; Large MK; Whitmire JK; Altman JD; Ruddle NH; Ahmed R
    J Virol; 2002 Apr; 76(8):3943-51. PubMed ID: 11907234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and anatomic location of PD-1
    Im SJ; Obeng RC; Nasti TH; McManus D; Kamphorst AO; Gunisetty S; Prokhnevska N; Carlisle JW; Yu K; Sica GL; Cardozo LE; Gonçalves ANA; Kissick HT; Nakaya HI; Ramalingam SS; Ahmed R
    Proc Natl Acad Sci U S A; 2023 Oct; 120(41):e2221985120. PubMed ID: 37782797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutting edge: resident memory CD8 T cells occupy frontline niches in secondary lymphoid organs.
    Schenkel JM; Fraser KA; Masopust D
    J Immunol; 2014 Apr; 192(7):2961-4. PubMed ID: 24600038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy.
    Im SJ; Hashimoto M; Gerner MY; Lee J; Kissick HT; Burger MC; Shan Q; Hale JS; Lee J; Nasti TH; Sharpe AH; Freeman GJ; Germain RN; Nakaya HI; Xue HH; Ahmed R
    Nature; 2016 Sep; 537(7620):417-421. PubMed ID: 27501248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcription Factor IRF4 Promotes CD8
    Man K; Gabriel SS; Liao Y; Gloury R; Preston S; Henstridge DC; Pellegrini M; Zehn D; Berberich-Siebelt F; Febbraio MA; Shi W; Kallies A
    Immunity; 2017 Dec; 47(6):1129-1141.e5. PubMed ID: 29246443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliferating Transitory T Cells with an Effector-like Transcriptional Signature Emerge from PD-1
    Hudson WH; Gensheimer J; Hashimoto M; Wieland A; Valanparambil RM; Li P; Lin JX; Konieczny BT; Im SJ; Freeman GJ; Leonard WJ; Kissick HT; Ahmed R
    Immunity; 2019 Dec; 51(6):1043-1058.e4. PubMed ID: 31810882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment.
    Wherry EJ; Blattman JN; Murali-Krishna K; van der Most R; Ahmed R
    J Virol; 2003 Apr; 77(8):4911-27. PubMed ID: 12663797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical role for perforin-, Fas/FasL-, and TNFR1-mediated cytotoxic pathways in down-regulation of antigen-specific T cells during persistent viral infection.
    Zhou S; Ou R; Huang L; Moskophidis D
    J Virol; 2002 Jan; 76(2):829-40. PubMed ID: 11752172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.